Biotronik SE has been granted a patent for an implantable medical device that integrates a communication system for remote monitoring. The device establishes communication at initial operation, minimizing patient involvement and ensuring efficient monitoring with low power consumption. GlobalData’s report on Biotronik SE gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Biotronik SE, Neuromodulation implants was a key innovation area identified from patents. Biotronik SE's grant share as of June 2024 was 46%. Grant share is based on the ratio of number of grants to total number of patents.
Remote monitoring-enabled implantable medical device
The patent US12035995B2 describes an innovative implantable medical device designed to perform therapeutic or diagnostic functions while maintaining efficient communication with a remote monitoring system. The device features a communication component that initiates contact with the monitoring system at the start of its operation. This communication is established through a transmit signal that is sent repeatedly at predefined intervals, ensuring that the device consumes less than 20 mAs of current per day. The device is programmed to activate communication functions only when specific criteria are met, such as having established a certain number of successful connections within a defined timeframe. This design aims to optimize energy consumption while ensuring reliable data transmission.
Additionally, the patent outlines various configurations for the communication device, including the use of established protocols such as MICS, BLE, or Zigbee. The device is intended to remain operational within a patient for an extended period, allowing for continuous communication with the remote monitoring system. It is capable of transmitting monitoring data at regular intervals, further enhancing its functionality. The system also includes provisions for the remote monitoring system to receive signals from the implantable device and initiate a channel allocation procedure for effective communication. Overall, this patent presents a comprehensive approach to improving the functionality and efficiency of implantable medical devices in remote patient monitoring scenarios.
To know more about GlobalData’s detailed insights on Biotronik SE, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
